Conditions: Interstitial Cystitis Bladder Pain Syndrome
Keywords: Interstitial cystitis Bladder pain syndrome IC/BPS AQX-1125 SHIP1
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 69
Healthy volunteers: no

Brief summary:
The primary objective of this study is to evaluate the effect of 6 weeks of treatment with once daily administration of AQX-1125 compared to placebo on average daily pain in subjects with interstitial cystitis/bladder pain syndrome (IC/BPS), during and after treatment, using a standardized 11-point numerical rating scale (NRS) pain score recorded by electronic diary

Detailed description:

Arms:
arm 1: 1 x AQX-1125 Capsule daily arm 2: 1 x placebo capsule daily

Interventions: intervention 1: AQX-1125 intervention 2: Placebo
Intervention descriptions: intervention 1: Synthetic SHIP1 activator intervention 2: Double blind placebo capsule

Protocol document: